María de la Luz Herrera-Estrada

Dr. María de la Luz Herrera-Estrada

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2026 in Foods
Verified
Journal Article
Open access
PDF file
CGCarlos Cano Gonzalez
Carlos Cano Gonzalez
ECEliseo Cárdenas-Hernández
Eliseo Cárdenas-Hernández
María de la Luz Herrera-EstradaMaría de la Luz Herrera-Estrada
María de la Luz Herrera-Estrada
Miguel Ángel Aguilar-GonzalezMiguel Ángel Aguilar-Gonzalez
Miguel Ángel Aguilar-Gonzalez
JMJose L Martinez-Hernandez
Jose L Martinez-Hernandez
Cristobal N. AguilarCristobal N. Aguilar
Cristobal N. Aguilar
Solid-state fermentation (SSF) is a pivotal biotechnology in the circular economy, leveraging agri-food industrial waste and byproducts to produce high-value bioproducts while minimizing organic waste. By aligning with sustainability goals and zero-waste principles, SSF enables the production of enzymes, bioactive compounds, and secondary metabolites for food, agriculture, and biomedical applications. Recent advancements have optimized critical parameters, including substrate selection, culture conditions, and scalable bioreactor designs, enhancing process efficiency and reducing environmental impact. Despite progress, challenges persist in maximizing production yields and fostering industrial adoption. Addressing these hurdles, particularly through integrated environmental and techno-economic analyses, is essential to solidify SSF’s role as a sustainable and competitive bioprocessing method. This review analyzes the latest advances in SSF, including the valorization of food and agro-industrial wastes, innovative bioreactor designs, microbial engineering for more efficient strains, bioenergy production and its integration into biorefineries, and contributions to the circular bioeconomy. Thus, SSF emerges as a key technology in sustainable industrial biotechnology, offering eco-friendly alternatives and promoting a more efficient production model.

16 April 2026 in Fermentation
Verified
Journal Article
Open access
PDF file
María de la Luz Herrera-EstradaMaría de la Luz Herrera-Estrada
María de la Luz Herrera-Estrada
JSJOSE SANDOVAL-CORTES
JOSE SANDOVAL-CORTES
CGCarlos Cano Gonzalez
Carlos Cano Gonzalez
TGTeresinha Gonçalves-Silva
Teresinha Gonçalves-Silva
JMJose L Martinez-Hernandez
Jose L Martinez-Hernandez
Cristobal N. AguilarCristobal N. Aguilar
Cristobal N. Aguilar
Carotenoids are natural pigments of high industrial value, with recognized antioxidant properties, and are widely used in the food, cosmetic, and pharmaceutical industries. Oleaginous yeasts, such as Rhodotorula glutinis, represent a promising alternative for the sustainable production of these compounds through submerged fermentation, compared to their extraction from plant sources or chemical synthesis. This study aimed to optimize culture conditions to maximize biomass and carotenoid production in R. glutinis P4M422. To this end, the effects of various culture factors, including light, carbon-to-nitrogen (C/N) ratio, temperature, pH, and glycerol addition, on cell growth and pigment biosynthesis were evaluated. The results showed that agitation speed and C/N ratio are key variables in system performance, significantly influencing both growth and carotenoid accumulation. Under the established optimal conditions (210 rpm, C/N ratio of 50, red light, and 30 °C), a maximum volumetric yield of 343.1 mg/L and a productivity of 4.8 mg/L/h were achieved, representing a substantial improvement in process efficiency. These values position the R. glutinis P4M422 strain as a competitive alternative for the biotechnological production of carotenoids. Taken together, these findings confirm the efficiency of submerged culture as a platform for obtaining high-value-added biopigments and reinforce the potential of microbial fermentation systems as a sustainable, scalable, and controllable strategy for their production.

30 September 2026 in Spectroscopy Journal
Verified
Journal Article
Open access
PDF file
CGCarlos Cano Gonzalez
Carlos Cano Gonzalez
María de la Luz Herrera-EstradaMaría de la Luz Herrera-Estrada
María de la Luz Herrera-Estrada
ÉRÉrika Marcela Ríos-Peña
Érika Marcela Ríos-Peña
ATAndrés D. Torres-Martínez
Andrés D. Torres-Martínez
MCMariana Del Carmen-Jiménez
Mariana Del Carmen-Jiménez
Cristobal N. AguilarCristobal N. Aguilar
Cristobal N. Aguilar
Polyendocrine metabolic ovarian syndrome (PMOS), the recently proposed name for polycystic ovary syndrome (PCOS), is a heterogeneous endocrine-metabolic disorder characterized by reproductive abnormalities, insulin resistance, hyperandrogenism, dyslipidemia, chronic inflammation, and oxidative stress. This complexity limits the ability of individual biomarkers to fully reflect the syndrome’s pathophysiology, necessitating complementary analytical strategies for its characterization and monitoring. Consequently, spectrophotometric and colorimetric techniques offer rapid, accessible, and versatile tools for assessing various PMOS-associated biomarkers, while emerging spectroscopic approaches can provide complementary molecular information. This structured narrative review examines the primary applications of spectrophotometric and colorimetric methods for determining metabolic, endocrine, inflammatory, and oxidative biomarkers associated with the syndrome. Direct spectrophotometric assays were distinguished from immunoassays with absorbance detection, chromatographic methods coupled with UV detection, mass spectrometry-based platforms, and calculated clinical indices. It also addresses limitations regarding analytical specificity, biological variability, methodological heterogeneity, and the lack of standardized procedures. Furthermore, the integration of biomarkers—obtained through spectrophotometric, colorimetric, immunoassay-based, and emerging spectroscopic approaches—with multivariate analysis and artificial intelligence is proposed as a strategy for multidimensional patient profiling. Although these strategies could enhance patient stratification, metabolic monitoring, and precision medicine, their clinical implementation requires appropriate regulations, validation, and studies demonstrating reproducibility and clinical utility.